Amedica has been granted marketing clearance for its Valeo interbody fusion devices in Australia.
The Valeo product line is made entirely of Amedica’s proprietary medical grade silicon nitride ceramic—a composition intended to promote fusion with its nanostructured surface, osteoconductivity, osteoinductivity, anti-microbial properties, and ease of radiographic imaging.
Sonny Bal, chief executive officer of Amedica, says, “The successful outcomes from Australia are now validated by 45 scientific papers published by Amedica in top-tier peer journals, and clinical data that will be published throughout this year. We look forward to working with Australian surgeons.”
